In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Atritech closes $30mm round

Executive Summary

Medical device company Atritech raised $30mm through a late-stage venture round led by Thomas, McNerney & Partners. Split Rock Partners, Prism Ventures, Tullis-Dickerson, and Vector Group also participated in the financing. The company will use the funds to complete FDA review and then market launch of its Watchman closure device, designed to prevent stroke-causing blood clots from entering the circulatory system in patients with atrial fibrillation. The PROTECT AF clinical trials are comparing the device to warfarin drug treatment, the current standard of care.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register